Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Journal of Neuroscience Research|August 7, 2009
Taurine treatment inhibits CaMKII activity and modulates the presence of calbindin D28k, calretinin, and parvalbumin in the brainF Junyent, R Romero, L de Lemos, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2009
Use of combined androgen blockade for advanced prostate cancer in British ColumbiaAdeline Chau, Mário L de Lemos, Tom Pickles, et al.Journal of Neuroscience Research|April 14, 2011
Decrease of calbindin-d28k, calretinin, and parvalbumin by taurine treatment does not induce a major susceptibility to kainic acidF Junyent, D Porquet, L de Lemos, et al.Neuropathology and Applied Neurobiology|September 3, 2011
Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acidF Junyent, L de Lemos, E Verdaguer, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 6, 2008
Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administrationMário L de Lemos, Shirin Monfared, Tetyana Denyssevych, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 13, 2006
Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based databaseMário L de Lemos, Suzanne C Taylor, Jeff B Barnett, et al.European Heart Journal|December 25, 2010
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trialBenjamin M Scirica, Marc S Sabatine, Petr Jarolim, et al.Pharmacotherapy|August 12, 2000
A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysisC A Marra, L Frighetto, C B Quaia, et al.Free Radical Research|September 25, 2013
Melatonin suppresses nitric oxide production in glial cultures by pro-inflammatory cytokines through p38 MAPK inhibitionA Vilar, L de Lemos, I Patraca, et al.Bulletin of the World Health Organization|January 1, 1970
Smallpox eradication in Brazil, 1967-69E S de Carvalho Filho, L Morris, A L de Lemos, et al.Pageof 5